Europe • Frankfurt Stock Exchange • FRA:EVT • DE0005664809
Taking everything into account, EVT scores 3 out of 10 in our fundamental rating. EVT was compared to 22 industry peers in the Life Sciences Tools & Services industry. EVT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EVT has a expensive valuation and it also scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.97% | ||
| ROE | -19.87% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.82% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.27 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.03 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 1298.09 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 3 / 10 to EVT.DE.
ChartMill assigns a valuation rating of 1 / 10 to EVOTEC SE (EVT.DE). This can be considered as Overvalued.
EVOTEC SE (EVT.DE) has a profitability rating of 1 / 10.
The financial health rating of EVOTEC SE (EVT.DE) is 5 / 10.
The Earnings per Share (EPS) of EVOTEC SE (EVT.DE) is expected to grow by 50.73% in the next year.